Peter M. Chakoutis
Keine laufenden Positionen mehr
Profil
Peter M.
Chakoutis served as the Chief Financial Officer at DUSA Pharmaceuticals, Inc. and as the Vice President-Finance at Harvard Apparatus Regenerative Technology, Inc. He also briefly served as the Chief Financial & Accounting Officer at Harvard Apparatus Regenerative Technology, Inc. Mr. Chakoutis holds an undergraduate degree from Norwich University and a graduate degree from Bentley Graduate School of Business.
Ehemalige bekannte Positionen von Peter M. Chakoutis
| Unternehmen | Position | Ende |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Finanzdirektor/CFO | 29.10.2020 |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Finanzdirektor/CFO | 17.01.2020 |
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Finanzdirektor/CFO | 01.04.2005 |
Ausbildung von Peter M. Chakoutis
| Norwich University | Undergraduate Degree |
| Bentley Graduate School of Business | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |
